FindTrial
Sign In

role of glucagon in hypoglycemia

Role of alpha and beta cell secretory function in predicting hypoglycemia in patients with Diabetes Mellitus: A hospital based pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050967
Enrollment
76
Registered
2023-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E08-E13- Diabetes mellitus

Interventions

Intervention1: nil: nil

Sponsors

AIIMS, Raipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. A confirmed diagnosis of Diabetes on treatment with insulin with or without oral hypoglycemic agents (OHAs) other than insulin secretagogues 2. Informed consent

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Chronic kidney disease more than KDIGO stage 3 3. Sepsis 4. Acute coronary syndrome 5. Insulin secretagogue therapy

Design outcomes

Primary

MeasureTime frame
the correlation between basal serum glucagon level and incident hypoglycemia in DM patients on insulin based therapy during a follow up period of 2 weeks.Timepoint: 14 days—

Secondary

MeasureTime frame
1. The correlation between basal serum glucagon level and time in target range in insulin treated DM patients by using CGMS. 2. The correlation between basal serum C-peptide with time in target range (TIR) Timepoint: 14 days—

Countries

India

Contacts

Public ContactRohini Rokkam

AIIMS Raipur

rohinirokkam@aiimsraipur.edu.in08374063614

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026